CLINICAL TRIALS PROFILE FOR SYNERA
✉ Email this page to a colleague
All Clinical Trials for SYNERA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00530803 ↗ | The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children | Completed | Montefiore Medical Center | Phase 2 | 2007-06-01 | This study compares the efficacy of the Synera patch with Eutectic Mixture of Local Anesthetics (EMLA) as a topical anesthetic for venipuncture in pediatric patients. |
NCT00564785 ↗ | Synera™ for Epidural Needle Insertion | Completed | Duke University | Phase 4 | 2007-02-01 | We hypothesized that the analgesic effect of Synera™ analgesic patch would be superior to traditional infiltration with lidocaine for pain of epidural needle insertion in laboring parturients. |
NCT00564785 ↗ | Synera™ for Epidural Needle Insertion | Completed | IWK Health Centre | Phase 4 | 2007-02-01 | We hypothesized that the analgesic effect of Synera™ analgesic patch would be superior to traditional infiltration with lidocaine for pain of epidural needle insertion in laboring parturients. |
NCT00747669 ↗ | Pharmacokinetic Study of Synera™ in Neonates and Infants | Suspended | ZARS Pharma Inc. | Phase 4 | 2008-09-01 | This study will measure the amount of lidocaine and tetracaine in the blood after a 30 minute application of Synera. |
NCT00891163 ↗ | Evaluate the Depth and Duration of Anesthesia | Completed | Endo Pharmaceuticals | Phase 4 | 2006-12-01 | The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch. |
NCT00891163 ↗ | Evaluate the Depth and Duration of Anesthesia | Completed | ZARS Pharma Inc. | Phase 4 | 2006-12-01 | The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch. |
NCT00991068 ↗ | Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome | Completed | ZARS Pharma Inc. | Phase 2 | 2009-09-01 | The purpose of the study is to explore the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SYNERA
Condition Name
Clinical Trial Locations for SYNERA
Trials by Country
Clinical Trial Progress for SYNERA
Clinical Trial Phase
Clinical Trial Sponsors for SYNERA
Sponsor Name